Trial
NCT02347228
Evaluate Safety, Tolerability, PK, Preliminary Clinical Activity of OB318 in Patients With Advanced Solid Malignancies
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Oneness Biotech Co., Ltd.
Collaborators
—
Condition
Advanced Solid Malignancies
Intervention
OB318 capsule
Why stopped
This decision is based on a strategic company decision to discontinue development of this program as part of our portfolio prioritization.
Provenance
Dataset: 2026-07-10 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-10